Inhibition of CTSD activity in the GBA1 mutant (WT/N370S) PD neurons with Pepstatin A caused a further significant increase in monomeric α-synuclein levels (Fig. 3 C and D). This evidence concerns the gene CTSD and Parkinson disease.